News
Waterland Private Equity has divested its stake in Belgian laboratory business Medhold Group to Australian-based Sonic Healthcare who has fully acquired the business.
The purchase price for Medhold is based on an enterprise value of €232m and represents an EBITDA multiple of approximately 8.4x before synergies.
Waterland invested in Medhold in December 2007 as part of an expansion deal, acquiring a 50% stake in the company.
Founded in 1980 the Medhold Group employs over 300 staff and operates from a new, purpose-built, state-of-the-art reference laboratory in Antwerp.
Related Analysis
Pan-European analysis
unquote"s pan-European magazine, Private Equity Europe, provides an overview of buyout and fundraising activity across Europe, data and statistics, as well as longer research pieces, analysis, comments from industry professionals and interviews.
Updating your subscription status
Regions

Advertisement
Private Equity jobs
Advertisement
Comments (Total 0 Comments)